Search Results for:
-
WASHINGTON NEWS BRIEFS: ORPHAN DRUG LEGISLATION MOVING THROUGH HOUSE
Although Devine's theme was slated to be "Exiting Strategies for Biotech Companies," he joked at the start of his speech that "survival strategies" might be a more relevant topic given the currently moribund public offering marketsBioWorld Today | Friday, June 17, 1994 -
RAC APPROVES NINE NEW PROTOCOLS _ SEVEN FOR CANCER
Jeffrey M. Ostrove, senior vice president and chief scientific officer of Magenta Corp., Rockville, Md., a company which performs safety- related contracting for biotech companies told BioWorld that those types of buildings "require constraints such as seamless flooring and ceiling, epoxy paint, and special air filtering capable of discriminating particles of less than 4 nanometers in diameter, and different air pressuresBioWorld Today | Monday, June 13, 1994 -
OTHER NEWS TO NOTE
It's based upon the view we are not a single-product or technology biotech company," Bell saidBioWorld Today | Wednesday, June 8, 1994 -
MOLECULAR BIOSYSTEMS TRIES TO TURN BEARS INTO BULLS
In these troubled economic times for biotech companies, it seems hard to tell which way is upBioWorld Today | Tuesday, May 31, 1994 -
GAINING ACCESS TO MARKETPLACE MAY BE TOUGHEST STEP
For biotech companies, that means FDA approval _ once the final barrier to product approval and profit _ now represents only the start of the questBioWorld Today | Wednesday, May 25, 1994 -
EXHIBITION GRASSROOTS LOBBYING IS KEY TO SETTING NATIONAL POLICY
But the stereotypical approach of hiring slick lobbyists to dole out money from political action committees (PACs) is not an option for most unprofitable, cash-starved biotech companies...Biotech companies are now scattered across 47 states, giving them a potential audience with nearly all of the 535 members of CongressBioWorld Today | Wednesday, May 25, 1994 -
EUROPEANS PUSH FOR BIOTECH EXPANSION
The appeal comes from the Senior Advisory Group on Biotechnology (SAGB), whose members (with combined sales of more than $300 million) are drawn from the ranks of Europe's leading biotech companies...Specific proposals in the white paper include the recommendation that Europe's stock exchanges make it easier for biotech companies to gain listingsBioWorld Today | Tuesday, May 24, 1994 -
DRUG SAFETY REPORTING REQUIREMENTS TO CHANGE
The new reporting rules will address several matters of particular concern to biotech companies, Lumpkin told BioWorldBioWorld Today | Tuesday, May 24, 1994 -
ACT, PHARMACIA TEAM UP IN CELL-SEPARATION AREA
We are a biotech company barely a year old and we will have revenues in 1994BioWorld Today | Monday, May 16, 1994 -
NEW U.K. FUND RAISES $100M FOR BIOTECH
Not all of the money will go to biotech companiesBioWorld Today | Friday, May 13, 1994 -
GENENTECH'S PAC TARGETS LAWMAKERS
Not surprisingly, Genentech's PAC methodically targets politicians on committees who are key to health care reform legislation, intellectual property and patent laws, science and technology issues and the federal budget. (See the chart, p. 4.) "Genentech has been far and away the most aggressive biotech company in D.C.," said Tom Rankin, public affairs manager at Immunex and administrator of his company's PACBioWorld Today | Thursday, May 5, 1994 -
ANOTHER BIG PHARMA-BIOTECH DEAL: ONYX, MILES VENTURE WORTH $75M
Collaboration between big pharmaceutical companies and small biotech companies with big ideas has become a trend...Instead of a royalty in return for worldwide rights, we are now seeing much richer terms for biotech companiesBioWorld Today | Wednesday, May 4, 1994 -
IBAH BEGINS TRADING AFTER MERGER
In September 1993, Affinity established a wholly-owned subsidiary to provide drug development services to pharmaceutical and biotech companiesBioWorld Today | Monday, May 2, 1994 -
MACROCHEM LICENSES NOVEL DRUG DELIVERY SYSTEM
It may have great advantages for biotech companies where most of the products are proteinsBioWorld Today | Wednesday, April 27, 1994 -
BASF LAUNCHES $95-MILLION BIOTECH R&D COMPANY
WORCESTER, Mass. - Nearly 350 people crowded into a circus- style tent here on Wednesday, erected next to the newest and largest, biotechnology research and development facility in this state, which already boasts of a 149-biotech-company communityBioWorld Today | Thursday, April 14, 1994 -
NEW JERSEY WANTS TO WOO BIOTECHNOLOGY COMPANIES
And Feldbaum said the executive of a mid-size biotech company scouting out sites for a manufacturing facility in Maryland was greeted recently at the airport by the state's secretary of commerce, spent three hours chatting with the mayor of the city where the plant might be built and had dinner with the governor...The topic: how New Jersey could creatively attract biotech companiesBioWorld Today | Tuesday, April 12, 1994 -
BRITISH FUND TO BUILD BIOTECH INVESTMENTS
expects to plug the investment gap for biotech companies that have already gained a stock exchange listing...This means that around 70 percent of the money could end up in biotech companies in North AmericaBioWorld Today | Tuesday, April 12, 1994 -
HUMANE GENOME PASSED MILESTONE
He noted that the patent office, declaring an "interference," has denied some biotech companies patents when two similar discoveries have been made within six months of each otherBioWorld Today | Monday, April 11, 1994 -
BRITISH BIOTECH SHARES BUCK THE TREND
According to the latest BioIndex from accountants Arthur Andersen, biotech companies have also done better than either the pharmaceutical companies or health care sector so far in 1994...Nonetheless there has been a decline in the Andersen BioIndex, which tracks the market capitalization of biotech companies quoted on the London Stock ExchangeBioWorld Today | Wednesday, April 6, 1994 -
CANINE WORM YIELDS PUTATIVE HUMAN ANTI-INFLAMMATORY AGENT
But, he allowed, "All biotech companies in our position, with a drug like this, would be looking for a partnerBioWorld Today | Friday, April 1, 1994
Category
Current Filters
- xbiotech companies
Related Keywords
Categories
- x BioWorld Today (1317)
- x BioWorld Insight (935)
- x BioWorld International (362)
- x Bio Perspectives (123)
- x State of the Industry Report (110)
- x BioWorld Snapshots (19)
- x Top 25 Drug Report (16)
- x BioWorld Genomics Review (12)
- x Recorded (5)
- x Executive Compensation Report (4)
- x RNAi Report (3)
- x Market-Leading Biotech Drugs (1)
- x Featured (1)
- x Biotech Innovations (1)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.